HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gulshan Ara Selected Research

Neoplasms (Cancer)

9/2010Assessment of cell viability, lipid peroxidation and quantification of DNA fragmentation after the treatment of anticancerous drug mitomycin C and curcumin in cultured human blood lymphocytes.
3/2008Activity of the histone deacetylase inhibitor belinostat (PXD101) in preclinical models of prostate cancer.
2/2008Antigenotoxic role of Centella asiatica L. extract against cyproterone acetate induced genotoxic damage in cultured human lymphocytes.
1/2007Nuclear factor-kappaB p65 small interfering RNA or proteasome inhibitor bortezomib sensitizes head and neck squamous cell carcinomas to classic histone deacetylase inhibitors and novel histone deacetylase inhibitor PXD101.
8/2006Activity of PXD101, a histone deacetylase inhibitor, in preclinical ovarian cancer studies.
2/2003Potent activity of soluble B7RP-1-Fc in therapy of murine tumors in syngeneic hosts.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Gulshan Ara Research Topics

Disease

6Neoplasms (Cancer)
09/2010 - 02/2003
5Chromosome Aberrations (Chromosome Abnormalities)
09/2010 - 12/2006
2Ovarian Neoplasms (Ovarian Cancer)
01/2010 - 08/2006
1Muscle Weakness
03/2021
1Premature Birth (Birth, Premature)
12/2020
1Bacterial Infections (Bacterial Infection)
12/2020
1Stillbirth
12/2020
1Perinatal Death
12/2020
1Birth Weight (Birth Weights)
11/2020
1Gestational Weight Gain
11/2020
1Fever (Fevers)
11/2020
1Oligohydramnios
07/2019
1Guillain-Barre Syndrome
01/2019
1Hypertension (High Blood Pressure)
04/2012
1Parkinson Disease (Parkinson's Disease)
03/2012
1Stomach Neoplasms (Stomach Cancer)
09/2010
1Inflammation (Inflammations)
05/2008
1Stomatitis
05/2008
1Mucositis
05/2008
1Prostatic Neoplasms (Prostate Cancer)
03/2008
1Urinary Bladder Neoplasms (Bladder Cancer)
10/2007
1Hematuria
10/2007
1Squamous Cell Carcinoma of Head and Neck
01/2007
1Carcinogenesis
01/2007

Drug/Important Bio-Agent (IBA)

4Histone Deacetylase InhibitorsIBA
03/2008 - 08/2006
4belinostatIBA
03/2008 - 08/2006
2Antineoplastic Agents (Antineoplastics)IBA
09/2010 - 08/2006
2Paclitaxel (Taxol)FDA LinkGeneric
01/2010 - 08/2006
2Small Interfering RNA (siRNA)IBA
03/2008 - 01/2007
2Cyproterone AcetateIBA
02/2008 - 12/2007
2Progesterone CongenersIBA
02/2008 - 12/2007
1Dexamethasone (Maxidex)FDA LinkGeneric
12/2020
1GlucocorticoidsIBA
12/2020
1MicronutrientsIBA
11/2020
1CarbohydratesIBA
11/2020
1Proteins (Proteins, Gene)FDA Link
11/2020
1Misoprostol (Cytotec)FDA LinkGeneric
07/2019
1Biological ProductsIBA
01/2019
1SteroidsIBA
04/2012
1Canrenoic Acid (Potassium Canrenoate)IBA
04/2012
1Masoprocol (Actinex)FDA Link
03/2012
1alpha-SynucleinIBA
03/2012
1Pharmaceutical PreparationsIBA
09/2010
1ApigeninIBA
09/2010
1Mitomycin (Mitomycin-C)FDA LinkGeneric
09/2010
1allicinIBA
07/2010
1AntioxidantsIBA
07/2010
1Sulfhydryl Compounds (Thiols)IBA
07/2010
1Secretory Leukocyte Peptidase InhibitorIBA
01/2010
1Chlormadinone Acetate (Chlormadinone)IBA
11/2008
1Fibroblast Growth Factors (Fibroblast Growth Factor)IBA
05/2008
1human FGF20 protein (velafermin)IBA
05/2008
1Reactive Oxygen Species (Oxygen Radicals)IBA
05/2008
1Tissue Inhibitor of Metalloproteinase-1IBA
03/2008
1trichostatin A (A 300)IBA
01/2007
1NF-kappa B (NF-kB)IBA
01/2007
1Transcription Factors (Transcription Factor)IBA
01/2007
1Cyclin D1IBA
01/2007
1Butyric Acid (Butanoic Acid)IBA
01/2007
1Bortezomib (Velcade)FDA Link
01/2007
1Proteasome InhibitorsIBA
01/2007
1Medroxyprogesterone Acetate (Depo-Provera)FDA LinkGeneric
12/2006
1Carboplatin (JM8)FDA LinkGeneric
08/2006
1Docetaxel (Taxotere)FDA Link
08/2006

Therapy/Procedure

2Artificial Respiration (Mechanical Ventilation)
03/2021 - 01/2019
2Therapeutics
08/2006 - 02/2003
1Radiotherapy
05/2008
1Drug Therapy (Chemotherapy)
05/2008